Comparison of effects of telmisartan and valsartan on neointima volume in diabetes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Telmisartan (Primary) ; Valsartan (Primary)
- Indications Coronary artery disease; Hypertension
- Focus Pharmacodynamics
- Acronyms TELLME
- 03 Sep 2015 Biomarkers information updated
- 23 Jun 2011 Status changed from active, no longer recruiting to completed.
- 23 Jun 2011 Primary endpoint 'Neointimal-hyperplasia-measures' has been met.